Filter
1023
Text search:
pharmaceutical
performance
Featured
Recommendations
94
New Publications
318
Language
Document type
No document type
595
Studies & Reports
162
Guidelines
141
Strategic & Response Plan
50
Manuals
44
Training Material
14
Situation Updates
8
Fact sheets
7
Resource Platforms
2
Countries / Regions
Ethiopia
52
Kenya
47
India
44
Uganda
32
Global
30
South Africa
29
Nigeria
28
Liberia
25
Sierra Leone
23
Ghana
21
Tanzania
21
Zambia
20
Rwanda
19
Western and Central Europe
18
Namibia
16
Nepal
15
Malawi
15
Africa
13
Zimbabwe
11
Philippines
11
Indonesia
11
Bangladesh
11
Ukraine
11
Eastern Europe
10
Syria
9
Lesotho
9
Cambodia
8
Myanmar / Burma
8
Botswana
7
West and Central Africa
7
Eswatini/ Swaziland
6
Latin America and the Carribbean
6
Congo, Democratic Republic of
5
Cameroon
5
Benin
5
East and Southern Africa
5
Senegal
4
Thailand
4
South–East Asia Region
4
Asia
4
Burkina Faso
3
Germany
3
Western Pacific Region
3
Albania
3
South Sudan
2
Iraq
2
Jordan
2
Egypt
2
China
2
Brazil
2
Middle East and North Africa
2
Jamaica
2
Guinea
1
Mali
1
Saudi Arabia
1
Niger
1
Pakistan
1
Afghanistan
1
Lebanon
1
Chad
1
Ireland
1
Mozambique
1
Papua New Guinea
1
Sudan
1
North Macedonia
1
Eastern Europe and Central Asia
1
Fiji
1
Southern Africa
1
Laos
1
Timor Leste/ East Timor
1
Tajikistan
1
Bulgaria
1
Lithuania
1
Moldova
1
Iran
1
Kyrgyzstan
1
Australia
1
Vietnam
1
North America
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
495
Clinical Guidelines
61
Public Health
47
Key Resources
39
Pharmacy & Technologies
27
Women & Child Health
19
Capacity Building
10
Toolboxes
Pharmacy
92
AMR
73
COVID-19
67
TB
61
Mental Health
44
HIV
42
Rapid Response
26
Planetary Health
21
Caregiver
19
NTDs
19
NCDs
19
Global Health Education
16
Conflict
15
Health Financing Toolbox
14
Polio
6
Disability
5
Refugee
5
Specific Hazards
5
Ebola
4
Natural Hazards
4
Cholera
2
Health Financing
2
Zika
1
WHO would like to express its gratitude and appreciation to all Member States that provided information to the WHO survey on policies and activities at the national level in the area of antimicrobial resistance. The contribution of staff in WHO Regional and Country Offices has been invaluable: in ga
...
Pakistan Global Antibiotic Resistance Partnership (GARP) was formed in the wake of international and national efforts for AMR curtailment. A group of experts from microbiology, infectious diseases and veterinary medicine formed a core group at the organizational meet
...
South Africa has faced many challenges over the past two decades, accomplishing profound positive changes in the social structure and government of the nation. This has not yet fully translated into better health for the population, however, particularly the poorest segment. In fact, the p
...
In the kingdom of Bahrain, the national antibiotic committee will set the framework for the national response to AMR, especially bacterial resistance to antibiotics. It will be aligned with the World Health Organization’s (WHO) Global Action Plan on Antimicrobial Resistance, and with standards and
...
The present National action plan on antimicrobial resistance (AMR) with component of antimicrobial consumption (AMC) covering both human and agriculture sectors was developed based on the World Health Organization's (WHO) Global plan on AMR dated 2015. With the purpose to develop this plan, in May 2
...
This brief considers the rationale for shielding individuals at high risk of severe disease or death from COVID-19 in low- and middleincome countries. It provides an overview of proposed approaches to shielding, discusses the categories of individuals who may be identified for shielding, and outline
...
The “United Nations Framework for the immediate socio-economic response to COVID-19: Shared responsibility, global solidarity and urgent action for people in need” calls for protecting jobs, businesses and livelihoods to set in motion a safe recovery of societies and economies as soon as possibl
...
This curricula guide builds on several existing products of WHO and partners, aimed at supporting countries in their effort to address the first objective of the GAP-AMR (to improve awareness and understanding of AMR). It is targeted specifically at health educators and policy planners, and applies
...
Improvements in water sanitation and hygiene (WASH) and wastewater management in all sectors are critical elements of preventing infections and reducing the spread of antimicrobial resistance (AMR) as identified in the Global Action Plan to combat AMR. Yet, at present, WASH and wastewater management
...
WHO operational handbook on tuberculosis: module 4: treatment: tuberculosis care and support
recommended
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on Tuberculosis,
...
BMJ Global Health2020;5:e002914. doi:10.1136/bmjgh-2020-002914
The evidence produced in mathematical models plays a key role in shaping policy decisions in pandemics. A key question is therefore how well pandemic models relate to their implementation contexts. Drawing on the cases of Ebola and in
...
These guidelines provide evidence-based guidance on the use of peripartum antiviral prophylaxis in HBsAg-positive pregnant women for the prevention of mother-to-child transmission of HBV.
he pandemic has produced an unprecedented economic and social crisis, and it could generate a food, humanitarian, and political crisis if urgent measures are not taken. The policy options for addressing the pandemic entail consolidating national plans and achieving intersectoral consensus. The respo
...
Volume 2019, Article ID 4157574, 7 pages
https://doi.org/10.1155/2019/4157574
The two-year impact report for the Access to COVID-19 Tools (ACT) Accelerator details impact, case studies and timelines of key milestones for the Diagnostics, Therapeutics and Vaccines pillars, as well as the Health Systems and Response Connector.
In India, in response to the above and guided by our counterparts in the government of India, the UN agencies have developed the Novel Coronavirus Disease Joint Health Response Plan by UN Agencies and Partners, led by WHO-India, in close collaboration with the Ministry of Health and Family Welfare,
...
This document aims to provide guidance to healthcare facilities and healthcare providers in the European Union/European Economic Area (EU/EEA) and the United Kingdom (UK) on preparedness and infection prevention and control (IPC) measures for the management of possible and confirmed cases of COVID-1
...
The Global Strategy for Tuberculosis Research and Innovation will support the efforts of governments and other stakeholders to accelerate TB research and innovation, and improve equitable access to the benefits of research.
Availabl in Arabic, Chinese, English, French, Spanish and Russian
